Problems Associated with the Misuse of Drugs Among Young People. Benzydamine Poisoning – Case Study
Keywords:
benzydamine hydrochloride, poisoning, hallucinationsAbstract
Psychotropic substances market in Poland is regulated by the Drug Abuse Prevention Bill (Dz.U.2005 Nr 179 poz.1485) with amendments. Despite adding 17 new substances, which are typical ingredients in “legal highs”, to the prohibited drug list and introducing the concept of “substitute”, which gave the State Health Inspection a tool to simplify and accelerate the process of removing new psychotropic substances from the market, the supply of products of this kind to the Polish market did not decrease. Also, teenagers’ interest in the possibility of intoxicating themselves using substances found in popular over-the-counter medications which, when ingested in doses significantly exceeding therapeutic levels, cause psychoactive effects, is on the increase. The recreational usage of benzydamine, contained in gynaecological formulations, and dextromethorphane, the ingredient of medications used in dry cough treatment, is becoming alarming because of its scale. Dissociative effects, arousal, strong hallucinations caused by these drugs, and especially their combination with alcohol or cannabinoids may become a threat to the users’ health and life. In this article, we describe a case of acute poisoning due to benzydamine usage of a 17-year-old boy who was treated at the Department of Toxicology at Regional Hospital No 2 in Rzeszów.
Downloads
References
Ustawa z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii, Dz. U. Nr 179, poz. 1485 ze zm.
Kidawa M. Dopalacze – przejściowa moda czy realne zagrożenie? http://www.narkomania.org.pl/czytelnia/dopalacze-przejsciowa-moda-czy-realne-zagrozenie (8.12.2013)
Państwowa Inspekcja Sanitarna, Raport w sprawie dopalaczy – nowych narkotyków. Warszawa 2011; 15-17.
Ustawa z dnia 8 października 2010 r. o zmianie ustawy o przeciwdziałaniu narkomanii oraz ustawy o Państwowej Inspekcji Sanitarnej, Dz. U. Nr 213, poz. 1396.
Sierosławski J. Używanie alkoholu i narkotyków przez młodzież szkolną. Raport z ogólnopolskich badań ankietowych zrealizowanych w 2011 r. ESPAD. Warszawa 2011. http://www.cinn.gov.pl/portal?id=166545 (8.12.2013)
Gomółka E., Hydzik P., Matej T., Łata S., Rojek S. Metody immunoenzymatyczne w diagnostyce zatruć substancjami psychoaktywnymi – problemy analityczne i interpretacyjne. Prz Lek 2012; 69(8): 629-631.
Popławska M., Błażewicz A., Fijałek Z. The development of a liquid chromatography/tandem mass spectrometry screening method for the identification of various designer drugs and other substances of abuse. Mil Phar Med 2013; 6(3): 1-12.
Wilson MD, Ferguson RW, Mazer ME, Litovitz TL. Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000-2010. Clin Toxicol (Phila). 2011; 49(5):409-15.
Manaboriboon B, Chomchai C. Dextromethorphan abuse in Thai adolescents: A report of two cases and review of literature. J Med Assoc Thai. 2005;88(8): 242 245.
Mutschler J, Koopmann A, Grosshans M, Hermann D, Mann K, Kiefer F. Dextromethorphan withdrawal and dependence syndrome. Dtsch Arztebl Int. 2010;107(30): 537-40.
Fanaki NH, el-Nakeeb MA. Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. J Chemother 1992;4(6): 347-52.
Quane PA, Graham GG, Ziegler JB. Pharmacology of benzydamine. Inflammopharmacology 1998;6(2):95-107.
Charakterystyka produktu leczniczego Tantum Rosa https://www.osoz.pl/osoz-www/leki/szczegoly/574572246_tantum_rosa_prosz_do_sp_rozt_do_irygacji_6_sasz_0_0532_g_g (8.12.2013)
nazwy handlowe preparatów pochodzą z serwisu http://pharmindex.pl/index.php/page,Subst.SubstDetails/SubstID,136
Łukasik–Głębocka M. Dekstrometorfan i benzydamina – nowe substancje odurzające. Serwis Informacyjny Narkomania, 2008;2: 16-19.
Saldanha VB, Plein FA, Jornada LK. Non-medical use of benzydamine: a case report. J Bras Psiquiatr 1993;42(9):503-505.
Gómez-López L, Hernández-Rodríguez J, Pou J, Nogué S. Acute overdose due to benzydamine. Hum Exp Toxicol 1999;18: 471-473.
Sein Anand J, Łukasik – Głebocka M, Korolkiewicz R. Recreational abuse with benzydamine hydrochloride (tantum rosa). Clin Toxicol 2007;45: 198 – 199.
Opaleye ES, Noto AR, Sanchez ZM, Moura YG, Galduróz JC, Carlini EA. Recreational use of benzydamine as a hallucinogen among street youth in Brazil. Rev Bras Psíquíatr 2009;31: 208-13.
Balaban OD, Atagun MI, Yilmaz H, Yazar MS, Alpkan LR. Benzydamine abuse as a hallucinogen: a case report. BCP 2013;23(3): 276-279.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
